Devon W. Edwards
Associate, Intellectual Property
Devon W. Edwards is an associate in the Intellectual Property Department. His practice focuses primarily on district court and appellate level patent and trade secret litigation, including pre-litigation investigation, case analysis and management, trial preparation, and post-trial briefing and appeals. In addition to litigation, Devon also assists clients with various intellectual property issues, including patent, copyright, trade secret, and trademark analysis, clearance, protection, and assertion. Devon represents clients in a number of technologies, including the life sciences, high tech, and industrial sectors.
Experience
Devon is a member of the New York Intellectual Property Law Association.
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, February 2021
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, November 2020
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, July 2020
- Willkie Obtains Significant Victory for Hospira in Pharmaceutical Patent Litigation, April 6, 2020
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, April 2020
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, January 2020
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, October 2019
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, July 2019
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, April 2019
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, October 2018
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, July 2018
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, January 2018
- The Bio-Quarterly: Willkie’s Biologics and Biosimilars Newsletter, October 2017
- Supreme Court Ruling in TC Heartland Revives Focus on the Corporate “Place of Business,” Willkie Client Memo (May 25, 2017)
- Belcher v. Hospira (epinephrine) – Achieved judgment of non-infringement, invalidity, and unenforceability of asserted patent on behalf of Hospira in Hatch-Waxman litigation in District of Delaware.
- Insurent Agency Corp. v. Hanover Insurance Co. – Achieved victory on summary judgment for Hanover on all claims in S.D.N.Y., including allegations of copyright infringement and trade secret misappropriation.
- Merck v. Amneal (mometasone furoate) – Successfully defended district court judgment of non-infringement for Amneal at the Federal Circuit in appeal of Hatch-Waxman action.
Credentials
Education
New York University School of Law, J.D., 2015 Pennsylvania State University, B.A., 2012